About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Insights from 2023 ASH Annual Meeting
Lymphoma
Leukemia
Myeloma
MDS and MPN
Benign Hematology
Videos
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
C
ASH 2023 Insights: "ECOG-ACRIN E4412 Study of Ipi, Nivo, and Brentuximab Vedotin in Pts With R/R cHL"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Catherine Diefenbach
By
Insights from 2023 ASH Annual Meeting
FEATURING
Catherine Diefenbach
13 views
December 17, 2023
0 Comments
Login to view comments.
Click here to Login
Featured Video
06:51
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…
Feat.
D. Tremblay
Featured Video
15:14
Icahn School of Medicine at Mount Sinai
Safety Profile of Ruxolitinib in Patients With MF
Feat.
D. Tremblay
Lymphoma
06:43
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "The Best of MCL - Highlights & Key Takea…
Feat.
V. Yazbeck
11:40
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "The European MCL Network R2 Elderly Trial -…
Feat.
V. Ribrag
08:29
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "CAR T-Cell Therapy in Aggressive Lymphomas …
Feat.
A. Sureda
05:12
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Results From ELM-2, a Ph 2 Study of Odronex…
Feat.
J. C. Villasboas
08:30
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "PD-1 Blockade Before AutoSCT in R/R Classic…
Feat.
S. Desai
11:11
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Ibrutinib and Venetoclax in Symptomatic, Tr…
Feat.
J. Castillo
09:27
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Ph2 EpiRCHOP Study - Tazemetostat With R-CH…
Feat.
C. Sarkozy
09:10
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Acalabrutinib Added to Lenalidomide & R…
Feat.
P. Strati
06:00
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Effectiveness of CIT and Novel Therapies in…
Feat.
L. Nastoupil
09:05
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Time-Limited Exposure to a ROR1-Targeting B…
Feat.
P. Jasani
06:09
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Outcomes of Pts With Richter's Transfo…
Feat.
A. Kittai
05:45
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Anti-CD19 CAR T-Cell Therapy for Richter…
Feat.
A. Kittai
13:38
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "S1826 Trial - Nivo-AVD Compared to Brentuxi…
Feat.
S. Castellino
02:27
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Efficacy of Mosunetuzumab Monotherapy in Pa…
Feat.
C. Cheah
02:26
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Obinutuzumab, Lenalidomide, and Venetoclax …
Feat.
C. Cheah
10:19
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Final Analysis of the ELM-2 Study - Odronex…
Feat.
S. Ayyappan
10:57
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Mosunetuzumab + Polatuzumab Vedotin in Pts …
Feat.
E. Budde
13:46
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Smart Stop Trial - Lenalidomide, Tafasitama…
Feat.
J. Westin
30:24
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Treatment of Older Patients With HL in the …
Feat.
A. Evens
10:58
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "ViPOR Trial - Multi-Targeted Therapy With V…
Feat.
C. Melani
11:05
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Alliance A051301/BMT-CTN 1201 Study - Ibrut…
Feat.
C. Andreadis
06:30
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Pirtobrutinib in R/R FL - Results From the …
Feat.
N. Shah
11:11
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Prognostic Utility of MRD After Curative In…
Feat.
B. Sworder
08:59
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "SWOG S1826 Trial - Nivo-AVD vs. Bv-AVD in O…
Feat.
S. Rutherford
11:43
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Selection of Bispecific Antibody Therapies …
Feat.
M. Kamdar
16:09
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Addition of Inotuzumab Ozogamicin to the Co…
Feat.
I. Khouri
10:21
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "EOT Response Assessment After 1L Tx For Agg…
Feat.
M. Roschewski
13:06
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "ECOG-ACRIN E4412 Study of Ipi, Nivo, and Br…
Feat.
C. Diefenbach
18:05
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Optimal Management of R/R cHL - Post-Brentu…
Feat.
N. Grover
09:56
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Limited Duration Loncastuximab Tesirine Wit…
Feat.
J. Pablo Alderuccio
11:42
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Impact of Large Cells and Ki-67% on Outcome…
Feat.
N. Epperla
04:34
Insights from 2023 ASH Annual Meeting
ASH 2023 Summary: "Highlights and Key Takeaways in MCL"
Feat.
P. Jain
05:10
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Efficacy of Double Step-Up Dosing of AZD048…
Feat.
S. Gaballa
05:41
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Acalabrutinib With Rituximab as 1L Therapy …
Feat.
P. Jain
04:56
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Immune Reconstitution and Infection Pattern…
Feat.
M. Melody
10:28
Insights from 2023 ASH Annual Meeting
ASH 2023 Insights: "Multicenter Study of MCL Outcomes Following…
Feat.
Y. Wang